Abstract
A series of glucal-conjugated sterols as novel vascular leakage blocker were identified through design, synthesis and biologically evaluation. In addition, the structure-activity relationship (SAR) of the glucal-conjugated sterols focusing on the C17-side chain was also established. The sterol analogs linked with the rigid C17-side chain side chains exhibited potent cell survival activities. In particular, analog 21l, which possesses a cyclopentyl oxime moiety, was shown to have excellent pharmacological effects on retinal vascular leakage in a diabetic mouse model.
| Original language | English |
|---|---|
| Pages (from-to) | 184-194 |
| Number of pages | 11 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 75 |
| DOIs | |
| State | Published - 2014.03.21 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anti-apoptotic agents
- Diabetic retinopathy
- Ginsenoside Rk1
- Oxime
- Pregnenolone
- Tight junction
Fingerprint
Dive into the research topics of 'Glucal-conjugated sterols as novel vascular leakage blocker: Structure-activity relationship focusing on the C17-side chain'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver